Intuitive Surgical, Inc. (ISRG)
ISRG historical returns
Based on monthly dividend-adjusted prices. See the full breakdown on what if you had invested in ISRG.
ISRG annual returns by year
Congress trading in ISRG
11 members of Congress have disclosed trading ISRG — 17 purchases and 6 sales worth an estimated $233,000. Most recent disclosure: Jan 30, 2026.
See who in Congress traded ISRG →Insider activity in ISRG
ISRG's own executives and directors have made 0 open-market purchases ($0) and 20 sales ($5.0M) in the last 90 days, per SEC Form 4 filings. Most recent: Sep 15, 2026.
| Sep 15, 2026 | Widman Fredrik | VP Corporate Controller | Sell | $204,444 |
| Sep 15, 2026 | Widman Fredrik | VP Corporate Controller | Sell | $203,321 |
| Sep 11, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell | $9,145 |
| Sep 10, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell | $7,996 |
| Sep 9, 2026 | Brosius Mark | EVP & Chief Mfg and Supply Cha | Sell | $8,055 |
About Intuitive Surgical, Inc.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. It offers the da Vinci Surgical System that enables surgical procedures using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic endoluminal procedures enabling minimally invasive biopsies in the lung. The company also provides a suite of stapling, energy, and core instrumentation for its multi-port da Vinci surgical systems; progressive learning pathways to support the use of its technology; infrastructure of customer service and support specialists, a complement of services to its customers, including installation, repair, maintenance, 24/7 technical support, and proactive system health monitoring; and integrated digital capabilities providing connected offerings, streamlining performance for hospitals with program-enhancing insights. It sells its products through direct sales organizations, such as capital and clinical sales teams. Intuitive Surgical, Inc. was incorporated in 1995 and is headquartered in Sunnyvale, California.
ISRG Key Statistics
ISRG in plain English
- P/E ratio (46.5) — how many dollars you pay for each $1 of ISRG's yearly profit. That's high, so the market expects strong growth (and you're paying up for it).
- ROE (17.42%) — how efficiently the company turns shareholders' money into profit. This is a middling level.
- Profit margin (28.45%) — of every $1 in sales, this is what's left as profit after all costs.
- Dividend — ISRG doesn't pay a meaningful dividend; the return here comes from the share price, not cash payouts.
ISRG stock: frequently asked questions
What is Intuitive Surgical, Inc.'s stock price today?
Intuitive Surgical, Inc. (ISRG) last traded at $405.18 on the NASDAQ. Over the past 52 weeks the stock has traded between $328.57 and $603.88.
How much would $1,000 invested in ISRG 10 years ago be worth today?
A $1,000 investment in Intuitive Surgical, Inc. made 10 years ago would be worth about $5,031 today (dividends reinvested) — a total return of 403%, or 17.5% per year.
Does ISRG pay a dividend?
No — Intuitive Surgical, Inc. does not currently pay a meaningful dividend. Returns for shareholders come from changes in the share price.
What is ISRG's P/E ratio?
ISRG trades at a trailing price-to-earnings ratio of 46.5, and 33.5 times expected forward earnings. The P/E ratio tells you how many dollars investors pay for each $1 of the company's annual profit.
Do members of Congress trade ISRG stock?
Yes — 11 members of Congress have disclosed trades in ISRG under the STOCK Act, totaling 17 purchases and 6 sales worth an estimated $233,000.
What is Intuitive Surgical, Inc.'s ticker symbol?
Intuitive Surgical, Inc. trades under the ticker symbol ISRG on the NASDAQ.
Compare ISRG with peers
Data last refreshed from public sources. Figures may be delayed. Not investment advice.